FIGURE 2. Granulocyte count during hospitalization. IFX: infliximab infusion. GR-CSF: introduction of granulocyte stimulating factor.
Severe sporotrichoid fishtank granuloma following infliximab therapy for Crohn's disease
β Scribed by B. Ben Said; J. Kanitakis; I. Graber; F. Berard; J.F. Nicolas; J.C. Saurin; F. Augey
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 79 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1078-0998
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: Immunosuppressive therapy with anti-tnf-alpha antibodies is effective in patients with inflammatory bowel disease (ibd). however, there is an increased risk for infections associated with this therapy. ## Methods: Here, we report the case of a 58-year-old patient with crohn's disea
## Background: The efficacy of infliximab as maintenance therapy in patients with otherwise chronically active crohn's disease (cd) is well established. data concerning the linear growth response are sparse and can only be accrued in children. ## Methods: From september 2000 to february 2004, 32